<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: FTC Eyes Supply Dispute Between Drugmakers</title>
	<atom:link href="http://www.pharmalot.com/2009/11/ftc-eyes-supply-dispute-between-drugmakers/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2009/11/ftc-eyes-supply-dispute-between-drugmakers/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:27:12 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Fanny Farmer</title>
		<link>http://www.pharmalot.com/2009/11/ftc-eyes-supply-dispute-between-drugmakers/#comment-445343</link>
		<dc:creator>Fanny Farmer</dc:creator>
		<pubDate>Sat, 14 Nov 2009 13:06:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=19819#comment-445343</guid>
		<description>There is just as much or more, from a consumer standpoint with regard to potency and efficacy between brand name drugs and generics.  And if your doctor himself agrees, and indicates brand name needed for medical purposes, if there is a lower quality of generic drug available, even if insured, your copay could triple or quadruple.

From the sounds of it, this problem will continue for some time, until fatalities occur.

This should be a primary concern as part of the overall healthcare debate.</description>
		<content:encoded><![CDATA[<p>There is just as much or more, from a consumer standpoint with regard to potency and efficacy between brand name drugs and generics.  And if your doctor himself agrees, and indicates brand name needed for medical purposes, if there is a lower quality of generic drug available, even if insured, your copay could triple or quadruple.</p>
<p>From the sounds of it, this problem will continue for some time, until fatalities occur.</p>
<p>This should be a primary concern as part of the overall healthcare debate.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Robert</title>
		<link>http://www.pharmalot.com/2009/11/ftc-eyes-supply-dispute-between-drugmakers/#comment-445119</link>
		<dc:creator>Robert</dc:creator>
		<pubDate>Fri, 13 Nov 2009 18:02:28 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=19819#comment-445119</guid>
		<description>I can see the logic here for the drugmaker. Why spend millions on new drugs just to ship all the profits over to the generic drugmaker companies? On the other hand, paying $20 a pill for a drug like Provigil is absolutely ridiculous and far too pricey for the average American.</description>
		<content:encoded><![CDATA[<p>I can see the logic here for the drugmaker. Why spend millions on new drugs just to ship all the profits over to the generic drugmaker companies? On the other hand, paying $20 a pill for a drug like Provigil is absolutely ridiculous and far too pricey for the average American.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.148 seconds -->

